MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617057057 A) filed by Rage Biotech Pty Ltd on May 05, 2026, for Rnai Agents Targeting Rage.
Inventors include Wraight, Christopher John; Thomas, Merlin Christopher; Perez, Siro; Selimovic, Alisa; and Pickering, Raelene Jane.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention relates to RNA interference (RNAi) agents targeting RAGE mRNA, specifically exon 10 containing RAGE mRNA, and compositions comprising the same, and their use in treating RAGE-related disorders. In one aspect, the present invention provides a RNAi agent comprising a nucleotide sequence sufficiently complementary to an exon 10 RAGE mRNA sequence.
Disclaimer: Curated by HT Syndication.
